Things are falling into place for BIEL. After years of setting the table in terms of establishing worldwide distribution channels and clearing regulatory hurdles in over a dozen countries internationally BIEL is about realize increasing sales and profits imo. Throw in FDA clearance for wound care, post surgical healing and muscular skeletal pain relief for women, expanded and eventual full roll out in CVS and multiple suitors APPROACHING BIEL for possible buy out / partnership / licensing agreement and you have a stock poised for take off imo. Q4 financials I feel will be positive but will be an irrelevant side note very shortly. Smart investors are taking advantage of the low pps and buying now at these levels.
$Biel$